Open AccessDifferences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer in vitro under Cisplatin Treatment
Author(s) -
Przemysław Kieszkowski,
Dariusz Dąbruś,
Beniamin Oskar Grabarek,
Dariusz Boroń
Publication year - 2020
Publication title -
current pharmaceutical biotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.555
H-Index - 85
eISSN - 1873-4316
pISSN - 1389-2010
DOI - 10.2174/1389201021666200416102540
Subject(s) - cisplatin , transcriptome , endometrial cancer , cancer research , cell culture , downregulation and upregulation , in vitro , angiogenesis , gene expression , biology , oncology , cancer , microbiology and biotechnology , chemistry , medicine , gene , biochemistry , chemotherapy , genetics
Semaphorin 3F (SEMA3F) plays a substantial role in carcinogenesis, because of its role in inducing angiogenesis, and creating a microenvironment for the developing tumor.